Capricor Therapeutics Operating Margin 2010-2025 | CAPR
Current and historical operating margin for Capricor Therapeutics (CAPR) over the last 10 years. The current operating profit margin for Capricor Therapeutics as of March 31, 2025 is -181.71%.
| Capricor Therapeutics Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-12-31 | $0.02B | $-0.04B | -195.45% |
| 2024-09-30 | $0.02B | $-0.04B | -156.52% |
| 2024-06-30 | $0.03B | $-0.03B | -111.11% |
| 2024-03-31 | $0.03B | $-0.03B | -96.30% |
| 2023-12-31 | $0.03B | $-0.02B | -96.00% |
| 2023-09-30 | $0.01B | $-0.03B | -221.43% |
| 2023-06-30 | $0.01B | $-0.03B | -300.00% |
| 2022-09-30 | $0.00B | $-0.03B | -1350.00% |
| 2021-12-31 | $0.00B | $-0.02B | 0.00% |
| 2021-06-30 | $0.00B | $-0.02B | 0.00% |
| 2021-03-31 | $0.00B | $-0.02B | 0.00% |
| 2020-12-31 | $0.00B | $-0.01B | 0.00% |
| 2020-09-30 | $0.00B | $-0.01B | 0.00% |
| 2020-06-30 | $0.00B | $-0.01B | 0.00% |
| 2020-03-31 | $0.00B | $-0.01B | 0.00% |
| 2019-12-31 | $0.00B | $-0.01B | 0.00% |
| 2019-09-30 | $0.00B | $-0.01B | -1000.00% |
| 2019-06-30 | $0.00B | $-0.01B | -1200.00% |
| 2019-03-31 | $0.00B | $-0.01B | -1400.00% |
| 2018-12-31 | $0.00B | $-0.02B | -1500.00% |
| 2018-09-30 | $0.00B | $-0.02B | 0.00% |
| 2018-06-30 | $0.00B | $-0.01B | 0.00% |
| 2018-03-31 | $0.00B | $-0.01B | -1300.00% |
| 2017-12-31 | $0.00B | $-0.01B | -650.00% |
| 2017-09-30 | $0.00B | $-0.01B | -433.33% |
| 2017-06-30 | $0.00B | $-0.02B | -375.00% |
| 2017-03-31 | $0.00B | $-0.02B | -425.00% |
| 2016-12-31 | $0.00B | $-0.02B | -425.00% |
| 2016-09-30 | $0.00B | $-0.02B | -425.00% |
| 2016-06-30 | $0.00B | $-0.02B | -375.00% |
| 2016-03-31 | $0.00B | $-0.01B | -325.00% |
| 2015-12-31 | $0.01B | $-0.01B | -240.00% |
| 2015-09-30 | $0.01B | $-0.01B | -220.00% |
| 2015-06-30 | $0.01B | $-0.01B | -180.00% |
| 2015-03-31 | $0.01B | $-0.01B | -140.00% |
| 2014-12-31 | $0.00B | $-0.01B | -125.00% |
| 2014-09-30 | $0.00B | $-0.01B | -166.67% |
| 2014-06-30 | $0.00B | $-0.01B | -250.00% |
| 2014-03-31 | $0.00B | $-0.01B | -600.00% |
| 2013-12-31 | $0.00B | $-0.01B | 0.00% |
| 2013-09-30 | $0.00B | $0.00B | -200.00% |
| 2012-12-31 | $0.00B | $0.00B | -150.00% |
| 2012-03-31 | $0.00B | $-0.01B | -500.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.331B | $0.022B |
| Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.206B | 27.56 |
| Boston Scientific (BSX) | United States | $152.664B | 38.22 |
| Stryker (SYK) | United States | $149.191B | 31.19 |
| EssilorLuxottica (ESLOY) | France | $131.913B | 0.00 |
| Medtronic (MDT) | Ireland | $115.147B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.094B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.531B | 24.85 |
| ResMed (RMD) | United States | $37.280B | 28.00 |
| GE HealthCare Technologies (GEHC) | United States | $34.547B | 16.40 |
| Agilent Technologies (A) | United States | $32.221B | 21.01 |
| Terumo (TRUMY) | Japan | $24.355B | 31.64 |
| Koninklijke Philips (PHG) | Netherlands | $23.476B | 16.47 |
| Insulet (PODD) | United States | $20.287B | 79.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.641B | 11.97 |
| Baxter (BAX) | United States | $14.559B | 10.87 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.951B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.729B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.148B | 12.99 |
| Perrigo (PRGO) | Ireland | $3.724B | 9.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.715B | 16.59 |
| Haemonetics (HAE) | United States | $3.575B | 16.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.342B | 27.77 |
| ICU Medical (ICUI) | United States | $3.072B | 22.66 |
| LeMaitre Vascular (LMAT) | United States | $1.867B | 41.72 |
| QuidelOrtho (QDEL) | United States | $1.864B | 12.82 |
| AtriCure (ATRC) | United States | $1.504B | 0.00 |
| Acuren (TIC) | United States | $1.431B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.238B | 15.82 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Green Thumb Industries (GTBIF) | United States | $1.212B | 27.26 |
| Neogen (NEOG) | United States | $1.068B | 13.67 |
| BioLife Solutions (BLFS) | United States | $1.006B | 0.00 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.788B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Tilray Brands (TLRY) | Canada | $0.607B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.571B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Surmodics (SRDX) | United States | $0.446B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.321B | 11.82 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.300B | 0.00 |
| Quanterix (QTRX) | United States | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.30 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.75 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| Omeros (OMER) | United States | $0.206B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.202B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.197B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.87 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.152B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.16 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.87 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.76 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 49.29 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |